|
Jun 21
|
Top Stock Movers Now: FactSet, Sarepta Therapeutics, Spirit AeroSystems, and More
|
|
Jun 21
|
US indexes open mixed, pharmaceutical stocks climb: Morning Brief
|
|
Jun 21
|
Sarepta Stock Surges On FDA News; Industrial Stock In Buy Zone
|
|
Jun 21
|
Stocks to Watch Friday: Nvidia, Micron, Sarepta, CarMax
|
|
Jun 21
|
Sarepta Therapeutics' Gets Label Expansion for Elevidys in 'Best-case Scenario,' BofA Securities Says
|
|
Jun 21
|
Sarepta Gains as FDA Official Overrules Staff to Approve Therapy
|
|
Jun 21
|
Sarepta Stock Surges on Expanded Elevidys Approval. It’s a ‘Best-Case’ Scenario for Shares.
|
|
Jun 21
|
Sarepta surges on expanded approval of muscular dystrophy drug
|
|
Jun 21
|
Sarepta Therapeutics Soars on Expanded Approval for Its Muscular Dystrophy Drug
|
|
Jun 13
|
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
|
|
Jun 13
|
Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open for a Rival
|
|
Jun 13
|
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
|
|
May 24
|
Implied Volatility Surging for Sarepta (SRPT) Stock Options
|
|
May 5
|
Earnings Beat: Sarepta Therapeutics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
|
|
May 4
|
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
|
|
May 3
|
Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
|
|
May 2
|
Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says
|
|
May 2
|
Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
|
|
May 2
|
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Q1 2024 Sarepta Therapeutics Inc Earnings Call
|